Automera
PrivateLast Round
Seed
Jul 23, 2026
Total Funding Raised
$16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Automera operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in September 2023.
Automera is a biotechnology company that develops autophagy-targeting chimera small molecules (AUTACs) for targeted protein degradation to treat cancer, inflammation, and central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Automera Comparables
Compare Automera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AUTOTAC Bio | 89% | |
| Casma Therapeutics | 86% | |
| Attec Biotech | 85% |
For institutional investors. Book with your work email.
Automera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 23, 2026 | ||||
| Series A | Sep 27, 2023 |
For institutional investors. Book with your work email.
Automera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series A |
| Xora Innovation | Series A |
| ClavystBio | Series A |
| EDBI | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 145% MoM, reaching 2.6K.
- Jul 23, 2026
$1M raised in Seed Round.
For institutional investors. Book with your work email.
Automera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Automera's valuation, stock price, and market status.
Is Automera a public or private company?
Automera is a private company.
What is the current stock price of Automera?
Automera is a private company, so its shares have no public market price. Caplight tracks Automera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Automera worth (valuation)?
Valuation information for Automera is not publicly available.
Can I buy Automera stock?
Automera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Automera's last funding round?
Automera's most recent funding round was Seed on July 23, 2026.
Who are the main investors in Automera?
Key investors in Automera include Accelerator Life Science Partners, ClavystBio.
Will Automera IPO soon?
No public IPO plans have been announced for Automera.
How can I track Automera secondary market activity?
Caplight tracks bids, offers, and trades in Automera's shares on secondary markets.